Wednesday, June 8th, 2016 - Market Reports Online

MarketReportsOnline.com adds "Global Intravenous (IV) Iron Drugs Market Report: 2016 Edition" report to its research store.

Iron is vital for multiple bodily functions, most importantly for the production of hemoglobin for red blood cells which are responsible for transporting oxygen in the blood. As an element, the only source of iron is from the diet. There is no way the body can produce iron itself. Intravenous (IV) treatment, in a broad sense, covers all the types of medications delivered intravenously, i.e. directly into the vein, through intravenous drip.

Complete report available at http://www.marketreportsonline.com/481407.html.

Compared to the other routes of infusing medications, the intravenous route is the fastest way to deliver fluids and medications throughout the body. The first iron product for intravenous use was high-molecular-weight iron dextran. Some of the major areas of IV iron application include gynecology, gastroenterology, oncology and surgeries. Hemoglobin, Ferritin, Transferrin, and Hepcidin are major molecules which are critical in the function and regulation of iron.

The key factors driving growth of the global I.V. iron industry include increase in number of dialysis cases, increasing global healthcare expenditures, rising ageing population, increasing life expectancy rate, growing number of ERSD patients and rising medicines expenditures. Some of the noteworthy trends and developments of this industry are new product development, introduction of the first generation drugs InFed (iron dextran) and Dexeferrum (iron dextra) and feraccru treatment penetration. However, the growth of this sector is being hindered by emerging anemia management therapies and associated risks.

The report analyzes the global iron products industry along with an extensive coverage of global, Europe and the US I.V. iron market. The global IV iron market witnesses intense competition with numerous top notch players; such as Galenica Pharmaceuticals, Actavis Inc, AMAG Pharmaceuticals; operating in the marketplace along with small budding players. As a part of analysis of fierce competition prevailing in the industry, product contention has been presented in the report. The company profiles of leading aforementioned players in the market are also incorporated in the report.

Purchase a copy of this Global Intravenous (IV) Iron Drugs Market Report: 2016 Edition research report at http://www.marketreportsonline.com/contacts/purchase.php?name=481407.

By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

Few Points from List of Tables from Intravenous (IV) Iron Drugs Market 2016 Edition Report:

Risk Factors for CKD

Emerging Non-Intravenous Therapies for Anemia Management

Comparison between Injectafer® and Venofer®

Summary of Feraccru vs. IV Iron Profile

Dependent & Independent Variables (2011-2015)

Correlation Matrix

Model Summary – Coefficient of Determination

Regression Coefficients Output

Browse Other Latest Reports on Pharmaceuticals Market:

The US Testosterone Market Report: 2016 Edition (http://www.marketreportsonline.com/481261.html) Testosterone industry is a prominent segment of the pharmaceutical industry. Testosterone is a steroid hormone which exerts effects on the males throughout life. Testosterone is significant for maintaining muscle bulk, adequate levels of red blood cells, bone growth, a sense of well-being, and sexual function. Low testosterone may result in decreased sex drive, erectile dysfunction, depression and loss of muscle mass.

Global Spinal Cord Stimulation Market Report: 2016 Edition (http://www.marketreportsonline.com/481194.html) Chronic pain is an unpleasant sense of discomfort that persists or progresses over a long period of time. A chronic back pain can be treated through spinal cord stimulation (SCS) therapy. It is a process that uses soft thin wires with electrical leads to be placed in the spinal column through needle so as to cure chronic back pain. This process doesn’t eliminate the pain; it just interferes with the signals sent to the brain. The SCS surgery is performed in two stages: trial stimulation and permanent implantation.

About Us:
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Contact Us:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
Tel: + 1 888 391 5441
E-mail: [email protected]

File Library

Contact Profile

Market Reports Online


MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.


Ritesh Tiwari
P: + 1 888 391 5441
W: www.marketreportsonline.com/

Keywords

intravenous iron drugs, intravenous iron drugs market, intravenous iron drugs industry, global intravenous iron drugs market, i.v. iron drug, i.v. iron drug market, iron product, iron product market, global iron product market

Categories

Newsrooms

Sharing

More Formats